Home
University of Bergen
The Department of Biomedicine

News archive for The Department of Biomedicine

PFN2 co-operates with NAA80 to acetylate actin
The cell motility regulator NAA80 is assisted by Profilin 2 (25.09.2020)
Actin is modified by N-terminal acetylation which regulates its role in steering cellular architecture and cell motility. Now the machinery performing this acetylation is uncovered.
The NAA10 Asn101Lys variant disrupts the NAA10-NAA15 (NatA) complex and thereby the ability of this complex to carry out protein N-terminal acetylation.
Novel gene variants linked to developmental delay and hemihypertrophy (25.09.2020)
Several variants of the NAA10 gene have been found in patients suffering from developmental delay and hemihypertrophy. NAA10 steers the most common protein modification in humans: N-terminal acetylation.
Brain cancer is different from other cancers (25.09.2020)
Rolf Bjerkvig of the group for translational cancer research has given a lecture at the Norwegian science festival "Forskningsdagene" in 2020. You can watch a video at the Norwegian Cancer Union.
bilde_til_sak_om_utstilling_hovedbilde.jpg
Pioneers of molecular biology (16.09.2020)
Few people know the researchers Agnar Nygaard and Kjell Kleppe, but in the 1960s they were part of the world elite that laid the foundation for today's COVID-19 tests. Two permanent exhibitions about the pioneers have now been opened.
Pictures of Monica Hellesvik, Hanne Øye, Henriette Aksnes
Research from home (16.09.2020)
On Thursday 12th of March, the University of Bergen was shut down on short notice. Employees and students left their study and workplaces, worried about the recently declared pandemic situation and how the next weeks and months would be like.